NYSE: MRKMerck & Co Inc Earnings & Revenue
MRK past earnings growth
How has MRK's earnings growth performed historically?
Company
14.72%
Industry
10.68%
Market
82.89%
MRK's earnings have grown slower (3.78% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
MRK's earnings have grown slower (3.78% per year) than the US market average (77.34%)
Performance
MRK's earnings growth is accelerating - its growth over the last year (14.72%) is above its 5-year compound annual rate (3.78%)
Performance
MRK past revenue growth
How has MRK's revenue growth performed historically?
Company
6.37%
Industry
6.62%
Market
16.55%
MRK's revenue has grown slower (3.23% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
MRK's revenue has grown slower (3.23% per year) than the US market average (15.67%)
Performance
MRK's revenue growth is accelerating - its growth over the last year (6.37%) is above its 5-year compound annual rate (3.23%)
Performance
MRK earnings and revenue history
Current Revenue
$47.2B
Current Earnings
$10.5B
Current Profit Margin
22.20%
MRK's has not demonstrated consistent long-term earnings growth over the past 10 years (-10.22%)
Performance
MRK Return on equity
Current Company
39.30%
Current Industry
10.90%
Current Market
-36.30%
MRK's Return on Equity (39.30%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance
MRK Return on assets
Current Company
12.20%
Current Industry
8.50%
Current Market
6.20%
MRK is generating higher Return on Assets (12.20%) than the US Drug Manufacturers - General industry average (8.27%)
Performance
MRK Return on capital employed
Current Company
18.23%
Current Industry
12.80%
MRK has gotten more efficient at generating Return on Capital (18.23%) compared to 3 years ago (8.04%)
Performance
MRK earnings dates
- Next earnings date
- Oct 27, 2020
Merck & Earnings & Revenue FAQ
What were MRK's earnings last quarter?
On Apr 28, 2020, Merck & (NYSE: MRK) reported Q1 2020 earnings per share (EPS) of $1.27, up 12.39% year over year. Total Merck & earnings for the quarter were $3.22 billion. In the same quarter last year, Merck &'s earnings per share (EPS) was $1.13.
What was MRK's revenue last quarter?
On Apr 28, 2020, Merck & (NYSE: MRK) reported Q1 2020 revenue of $12.06 billion up 11.47% year over year. In the same quarter last year, Merck &'s revenue was $10.82 billion.
What was MRK's earnings growth in the past year?
As of Q4 2020, Merck &'s earnings has grown 14.72% year over year. This is 4.04 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. Merck &'s earnings in the past year totalled $10.48 billion.
What was MRK's revenue growth in the past year?
As of Q4 2020, Merck &'s revenue has grown 6.37% year over year. This is 0.25 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. Merck &'s revenue in the past year totalled $47.19 billion.
What is MRK's earnings date?
Merck &'s earnings date is Oct 27, 2020. Add MRK to your watchlist to be reminded of MRK's next earnings announcement.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
